Exploring copper chelation in Alzheimer's disease protein
ORAL
Abstract
Alzheimer's disease (AD) is a neurodegenerative disorder affecting millions of aging people in the U.S. alone. Clinical studies have indicated that metal chelation is a promising new approach in alleviating the symptoms of AD. Our study explores the as yet undetermined mechanism of copper chelation in amyloid-$\beta$, a protein implicated in AD. The structure of amyloid-$\beta$ is derived from experimental results and incorporates a planar copper-ion-binding structure in a semi-solvated state. We investigate the chelation process using the nudged elastic band method implemented in our {\it ab initio} real-space multigrid code. We find that an optimal sequence of unbonding and rebonding events as well as proton transfers are required for a viable chelation process. These findings provide fundamental insight into the process of chelation that may lead to more effective AD therapies.
–
Authors
-
Frisco Rose
CHiPS/NCSU
-
Miroslav Hodak
North Carolina State University, CHiPS/NCSU
-
J. Bernholc
CHiPS/NCSU, North Carolina State University, NC State University, Raleigh and ORNL, Oak Ridge, TN